Phytochemical Insights and Therapeutic Potential of Chamaenerion angustifolium and Chamaenerion latifolium
Molecules · 2025
DOI: 10.3390/molecules30051186 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Akmaral Kozhantayeva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of New Chemical Technologies, L.N. Gumilyov Eurasian National University, Satpayev Street 2, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Phytochemicals, Plant Extracts. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan, Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.
Abstract (Originalsprache)
The Chamaenerion genus, particularly Chamaenerion angustifolium and Chamaenerion latifolium, is recognized for its rich phytochemical composition and extensive medicinal properties. These species are abundant in polyphenols, flavonoids, and tannins, which contribute to their potent antioxidant, antimicrobial, and anticancer activities. This review provides a comprehensive analysis of their phytochemical constituents, with an emphasis on how processing methods, including fermentation, influence bioactivity. Notably, fermentation enhances the levels of key bioactive compounds, such as oenothein B, gallic acid, and ellagic acid, thereby increasing their pharmacological potential. Additionally, this review evaluates the biological activities of Chamaenerion species in relation to their chemical composition, while also considering the limitations of current studies, such as the lack of in vivo or clinical trials. The literature for this review was sourced from scientific databases, including PubMed, Scopus, and ScienceDirect, covering research from 2010 to 2024. Future studies should focus on optimizing extraction methods, elucidating synergistic bioactivities, and conducting in-depth clinical trials to validate their efficacy and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of New Chemical Technologies, L.N. Gumilyov Eurasian National University, Satpayev Street 2, Astana 010000, Kazakhstan.
- Department of Chemistry, Faculty of Natural Sciences, L.N. Gumilyov Eurasian National University, Satpayev Street 2, Astana 010000, Kazakhstan.
- Faculty of Science and Technology, Yessenov University, Aktau 130000, Kazakhstan.
- Department of General and Biological Chemistry, NJSC "Astana Medical University", Astana 010000, Kazakhstan.
ORCID-Profile: Akmaral Kozhantayeva, Zhanar Iskakova, Ardak Sapiyeva, Moldir Arkharbekova, Yerbolat Tashenov
Förderung
- The Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
- Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Kozhantayeva, A., Iskakova, Z., Ibrayeva, M., Sapiyeva, A., Arkharbekova, M., & Tashenov, Y. (2025). Phytochemical Insights and Therapeutic Potential of Chamaenerion angustifolium and Chamaenerion latifolium. Molecules. https://doi.org/10.3390/molecules30051186
Vancouver
Kozhantayeva A, Iskakova Z, Ibrayeva M, Sapiyeva A, Arkharbekova M, Tashenov Y. Phytochemical Insights and Therapeutic Potential of Chamaenerion angustifolium and Chamaenerion latifolium. Molecules. 2025. doi:10.3390/molecules30051186
BibTeX
@article{Kozhantayeva2025,
author = {Kozhantayeva, Akmaral and Iskakova, Zhanar and Ibrayeva, Manshuk and Sapiyeva, Ardak and Arkharbekova, Moldir and Tashenov, Yerbolat},
title = {Phytochemical Insights and Therapeutic Potential of Chamaenerion angustifolium and Chamaenerion latifolium},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30051186}
}
EUVIMED